Details of the Drug
General Information of Drug (ID: DMDLTCU)
Drug Name |
Lotilibcin
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Lotilibcin; JA-002; JA-003; WAP-8294A2; Acne therapy (dermatological formulation), Janus; Lotilibcin (injectable), aRigen; MRSA infection therapy (gel), Janus; S aureus infection therapy (gel), Janus; Lotilibcin (cream, acne), Janus; Lotilibcin (dermatological cream, acne), aRigen; Lotilibcin (gel, Staphycoccus infection), aRigen; Lotilibcin (gel, skin infections), Janus; WAP-8294A2 (injectable), aRigen; WAP-8294A2 (cream, acne), Janus; WAP-8294A2 (dermatological cream, acne), aRigen; WAP-8294A2 (gel, MRSA), aRigen; WAP-8294A2 (gel, skin infections), Janus
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 5 | Molecular Weight (mw) | 1562.8 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 26 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 19 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 23 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||